The 5th Annual Megan’s Miles Run/Walk, benefitting Muscular Dystrophy research at Nationwide Children’s Hospital, will be held on Sunday, May 27 at noon at Central Crossing High School. Attendees are encouraged to lace up their shoes and run or walk in this special fundraiser in honor of a Nationwide Children’s employee who passed away four years ago in a tragic car accident. Megan Schlaegel was a part of the research team at Nationwide Children’s and was involved in researching opportunities for improving treatment for muscular dystrophy. This year is particularly special because Megan’s contributions resulted in a major publication in the March 2012 issue of the Annals of Neurology describing the first newborn screening study of its kind that will be a lasting legacy for her hard work and dedication. Favorably changing the outcome of muscular dystrophy for kids with this disease will depend on starting treatment in the newborn period or shortly thereafter. “We will never forget Megan’s determination to make this possible for babies with the disease,” said Dr. Jerry Mendell, director of the Center for Gene Therapy at The Research Institute at Nationwide Children’s Hospital. In honor of her passion to find a cure, this event was organized by the family and friends of the Schlaegel family with the help of the Columbus Running Company Charity Fund. In 2011, Megan’s Miles raised nearly $12,000 for Nationwide Children’s and the team hopes to double last year’s contributions. The 4-mile run and 1.5-mile walk will begin and end at Central Crossing High School. Registration is $17 per person, $12 per person for groups/families of three or more, or $22 the day of the race. To register for Megan’s Miles, visit www.columbusrunning.com.
The 5th Annual Megan’s Miles Run/Walk, benefitting Muscular Dystrophy research at Nationwide Children’s Hospital, will be held on Sunday, May 27 at noon at Central Crossing High School.
Attendees are encouraged to lace up their shoes and run or walk in this special fundraiser in honor of a Nationwide Children’s employee who passed away four years ago in a tragic car accident. Megan Schlaegel was a part of the research team at Nationwide Children’s and was involved in researching opportunities for improving treatment for muscular dystrophy.
This year is particularly special because Megan’s contributions resulted in a major publication in the March 2012 issue of the Annals of Neurology describing the first newborn screening study of its kind that will be a lasting legacy for her hard work and dedication. Favorably changing the outcome of muscular dystrophy for kids with this disease will depend on starting treatment in the newborn period or shortly thereafter.
“We will never forget Megan’s determination to make this possible for babies with the disease,” said Dr. Jerry Mendell, director of the Center for Gene Therapy at The Research Institute at Nationwide Children’s Hospital.
In honor of her passion to find a cure, this event was organized by the family and friends of the Schlaegel family with the help of the Columbus Running Company Charity Fund. In 2011, Megan’s Miles raised nearly $12,000 for Nationwide Children’s and the team hopes to double last year’s contributions.
The 4-mile run and 1.5-mile walk will begin and end at Central Crossing High School. Registration is $17 per person, $12 per person for groups/families of three or more, or $22 the day of the race. To register for Megan’s Miles, visit www.columbusrunning.com.
